Compounds > pyrroles
Page last updated: 2024-08-18

pyrroles and fumagillin

pyrroles has been researched along with fumagillin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abman, SH; Gebb, S; Hirth, KP; Jakkula, M; Le Cras, TD; Tuder, RM; Voelkel, NF1
Caruthers, SD; Lanza, GM; Wickline, SA; Williams, TA; Winter, PM; Zhang, H1
Arbustini, E; Gambarin, FI1
Kishimoto, S; Sato, M; Tsunematsu, Y; Watanabe, K1

Other Studies

4 other study(ies) available for pyrroles and fumagillin

ArticleYear
Inhibition of angiogenesis decreases alveolarization in the developing rat lung.
    American journal of physiology. Lung cellular and molecular physiology, 2000, Volume: 279, Issue:3

    Topics: Angiogenesis Inhibitors; Animals; Animals, Newborn; Barium Sulfate; Body Weight; Cyclohexanes; Fatty Acids, Unsaturated; Gelatin; Heart; Indoles; Injections, Intra-Arterial; Lung; Neovascularization, Physiologic; Organ Size; Pulmonary Alveoli; Pulmonary Artery; Pyrroles; Rats; Rats, Sprague-Dawley; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Sesquiterpenes; Thalidomide

2000
Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis.
    JACC. Cardiovascular imaging, 2008, Volume: 1, Issue:5

    Topics: Angiogenesis Inhibitors; Animals; Aorta, Thoracic; Atherosclerosis; Atorvastatin; Carbocyanines; Cyclohexanes; Disease Models, Animal; Drug Carriers; Drug Synergism; Drug Therapy, Combination; Fatty Acids, Unsaturated; Heptanoic Acids; Heterocyclic Compounds, 1-Ring; Integrin alphaVbeta3; Liver; Magnetic Resonance Imaging; Nanoparticles; Neovascularization, Pathologic; Pyrroles; Rabbits; Sesquiterpenes; Time Factors

2008
Theranostic strategy against plaque angiogenesis.
    JACC. Cardiovascular imaging, 2008, Volume: 1, Issue:5

    Topics: Angiogenesis Inhibitors; Animals; Atherosclerosis; Atorvastatin; Carbocyanines; Cyclohexanes; Drug Carriers; Drug Synergism; Drug Therapy, Combination; Fatty Acids, Unsaturated; Heptanoic Acids; Heterocyclic Compounds, 1-Ring; Humans; Integrin alphaVbeta3; Magnetic Resonance Imaging; Nanoparticles; Neovascularization, Pathologic; Pyrroles; Sesquiterpenes; Time Factors

2008
Elucidation of Biosynthetic Pathways of Natural Products.
    Chemical record (New York, N.Y.), 2017, Volume: 17, Issue:11

    Topics: Biological Products; Biosynthetic Pathways; Cyclohexanes; Fatty Acids, Unsaturated; Fungi; Genes, Fungal; Heterocyclic Compounds, 4 or More Rings; Hydroxyquinolines; Models, Molecular; Piperazines; Pyrones; Pyrroles; Secondary Metabolism; Sesquiterpenes; Spiro Compounds

2017